Category: Research

Categories
Shares Technology Stocks

Marvell taking aim at cloud, 5G and automotive markets

Between data processing units, or DPUs, optical interconnect, and ethernet solutions, Marvell has one of the broadest networking silicon portfolios in the world, and we think it is primed to steal market share from incumbent Broadcom with bleeding-edge technology.

Marvell has exited its low-margin legacy markets of consumer hard disk drives and Wi-Fi chipsets to focus on its networking portfolio and used the acquisitions of Cavium, Avera, Aquantia, Inphi, and Innovium to expand out of its enterprise market niche into the rapidly growing data center and 5G markets.

Marvell’s recent financial history has been choppy as a result of CEO Matt Murphy’s aggressive overhaul of the business’ focus. Trends toward disaggregated networks and merchant silicon, as well as 5G and data center buildouts, would act as secular tailwinds for Marvell.

Financial Strength:

As of May 1, 2021, the firm carried $522 million in cash and $4.7 billion in total debt—largely taken on to acquire Inphi. Marvell is expected to exit fiscal 2022 with a gross debt/adjusted EBITDA ratio of 2.4 times, above its target of 2 times. As per the analysts, Marvell is expected to stay leveraged but to pay down debt as it matures.

The firm’s free cash flow generation is expected to ramp up toward $2 billion a year by fiscal 2026, up from just over $700 million in fiscal 2021, as it exacts material operating leverage with top-line growth.

The firm would be prudent to postpone any M&A until it returns below its debt/EBITDA target, following $11 billion spent so far in fiscal 2022 on Inphi and Innovium.

Bulls Say:

  • Marvell has best-of-breed data processing units and optical interconnect products that should allow it to benefit from the rapidly growing cloud and 5G markets.
  • We think the combination of Inphi and Innovium under the Marvell umbrella could give it a technological advantage to Broadcom in high-performance networking.
  • We expect Marvell to exact significant operating leverage as it incorporates acquisitions and adds volume to the top line.

Company Profile:

Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical

interconnections, application-specific integrated circuits (ASICs), and merchant silicon for ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.

(Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Global stocks Shares

Pointsbet Holdings delivered strong FY21 results with group revenue up by 159%

Investment Thesis:

  • U.S. growth opportunity– the U.S. online sports betting market continues to open following the 2018 supreme court ruling which legalise the industry. Market growth estimates forecast the industry to grow to US$51bn by 2033. 
  • Strong management team with a solid track record – the ability to grow market share in a competitive and mature market of Australia gives us some confidence the management team have the right strategy in place to build share in the U.S. 
  • Proprietary technology stack – The speed and usability are key differentiating factors. PBH operates proprietary technology, which it developed inhouse. This means new modifications and updates are easier to implement (i.e., more control) with inhouse tech versus outsourced (i.e., having to go to an external provider each time with an update). 
  • Cross sell opportunities with iGaming – PBH’s recently launched iGaming product (online casino) is already highlighting cross-sell opportunities to its customers.

Key Risks:

  • Rising competitive pressures
  • Adverse regulatory change in key operating jurisdictions (Australia / U.S.)
  • Loss of market share in key regions or growth rate fails to meet market expectations
  • Higher than expected costs – especially around investment in sales & marketing to drive market share
  • Trading on high PE-multiples / valuations means the Company is more prone to share price volatility
  • Cyber-attack on PBH’s platform

Key highlights:

  • PBH’s FY21 results were largely in line with expectations, with group revenue up +159% to $194.7m and gross profit up +129% to $87.6m YoY.
  • The recently launched iGaming product represents another growth opportunity (backed by a strong management team), with management noting that ~71% of all iGaming players have placed an in-play wager and 40% of cash active clients have placed an iGaming bet since launch.
  • The more mature market of Australia still has room to grow, with PointsBet, the no. 5 player (by online market share) and management still targeting 10% online market share by 2025.
  • Group normalised EBITDA for the year was a loss of $156.1m vs loss of $37.6m in the pcp, as PBH continues to invest in the business to scale the U.S. business and invests in its technology stack.
  • Australian Trading segment reported revenue of $150.7m (vs $68.2m in pcp) and EBITDA of $9.2m (vs $6.9m in the pcp).
  • USA segment reported revenue of $42.3m (vs $7.0m in pcp) and EBITDA loss of $149.6m (vs loss of $38.2m in pcp). During the year, PBH operational in six U.S. states: New Jersey, Iowa, Indiana, Illinois, Colorado, and Michigan.
  • Balance sheet is in a good position to support investment in growth, with pro forma cash balance of $665.2m (post the July 21 capital raising).

Company Description: 

PointsBet Holdings Ltd (PBH), founded in 2015, is a corporate bookmaker with operations in Australia and the United States (New Jersey, Iowa, Illinois and Indiana). PointsBet has developed a scalable cloud-based wagering platform which offers customers sports and racing wagering products. PBH’s key products include fixed odds sports, fixed odds racing and PointsBetting.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
IPO Watch

Mitre Mining Corporation Limited launched IPO to raise $5 million

Mitre Mining Corporation Limited opened the offer for its IPO on 21 August 2021 and closed the offer on 10 September 2021. The shares get listed on ASX on 30 September 2021.

The Offer is for an initial public offering of 25,000,000 Shares at an issue price of $0.20 each to raise $5 million. The Offer is open to investors with a registered address in Australia. The Company does not expect to pay dividends in the near future as its focus will primarily be on growing the business.

PURPOSES OF OFFER

The purposes of the Offer are to: 

  • Raise $5,000,000 pursuant to the Offer (before associated cost)
  •  Assist the Company to meet the requirements of ASX and satisfy Chapters 1 and 2 of the Listing Rules, as part of the Company’s application for admission to the Official List.
  •  Position the Company to seek to achieve the objectives.
  •  Provide the Company with access to equity capital markets for future funding needs; and 
  •  Enhance the public and financial profile of the Company.

PROPOSED USE OF FUNDS 

Following the Offer, it is anticipated that the following funds will be available to the Company.

SOURCE OF FUNDS($)
Existing cash reserves187,518
Proceeds from Offer5,000,000
TOTAL FUNDS AVAILABLE5,187,518

The following table shows the intended use of funds in the two-year period following admission of the Company to the Official List:

USE OF FUNDS – YEAR 1$%
Exploration expenditure1,900,00064.19
General administration and working capital513,54717.35
Estimated expenses of the Offer546,21518.46
Total – Year 12,959,762100.00
USE OF FUNDS – YEAR 2$%
Exploration expenditure1,512,14667.88
General administration and working capital715,61032.12
Total – Year 22,227,756100.00
TOTAL FUNDS ALLOCATED5,187,518100.00

Financial Information

ParticularsPeriod ended 30 june 2021 (in$)
Loss after income tax(98,535)
Cash at end of financial period254,321
Total current assets272,110
Total liabilities18,575

Mitre Mining Corporation Limited IPO Subscription Status (Bidding Detail)

Mitre Mining Corporation Limited IPO was oversubscribed and closed the trading at AUD$0.255 on 30 September and took a steep fall on 4th October at AUD$ 0.23.

About the company

Mitre Mining Corporation Limited  is a public company incorporated in Australia.The Company is an early stage mineral exploration and development company focused on gold and base metals discoveries within the Project.

Since its incorporation on 2 November 2020, the Company has secured the Tenement (EL9146) and has undertaken initial geological and geophysical desktop studies, interpretations and reconnaissance field work.

Following completion of the Offer, the Company intends to undertake exploration activities on the Project.

(Source: https://mitremining.com.au/prospectus/)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Shares Technology Stocks

Oracle transition to the cloud to get benefit from the Data boom

Shot of elegant smart businesswoman explaining a project to his colleagues with statistics on the computer on coworking place.

However, growth has been lacking as more customers shift their workloads to the cloud, bypassing Oracle’s solutions. Despite Oracle’s cloud migration efforts, cloud competition will likely provide headwinds for Oracle.

 However, we don’t view the company as being on the forefront of recent software trends, and new and potential customers appear to be looking past Oracle for their database needs. Database preferences are far wider today due to the sheer number of ways to manipulate data, and the different data storage practices this necessitates. In turn, Oracle is losing database market share to new database types that may be better suited to the cloud. 

Additionally, the transition to the cloud is prompting enterprises to change software vendors away from all-in-one ERP systems to application specific that are best of breed. In response, Oracle is banking on its second-generation cloud to not only cater to its traditional enterprise workloads, like supporting databases, but also general use workloads. However, we view Oracle’s cloud as sub-scale to Amazon and others and we doubt Oracle can close this gap soon. In our opinion, Oracle should still be successful in moving a significant amount of its traditional on-premises workloads to Oracle cloud. However, migrating all of its customers is not such a sure thing, as cloud-first software vendors have been able to take meaningful share from legacy Oracle customers.

Financial Strength 

Oracle is in healthy financial standing. As of fiscal 2020, Oracle had $43 billion in cash and equivalents versus $72 billion in debt. However, Oracle should generate robust free cash flow in the years ahead to settle these debt obligations over time. We think that Oracle will have the capital to increase its total annual dividends to $1.28 in fiscal 2025 from $0.96 in fiscal 2020, as the company continues to make share repurchases and acquisitions. However, we think that the magnitude of acquisitions will moderate as the company comes off of its buildout of its second-generation cloud product and has stressed their recent preference to build new capabilities in house. In terms of capital expenditures, we think Oracle will spend an average of $1.6 million per year over the next five years, as the company continues to require build outs for its cloud operations.

Bulls Say

  • Oracle’s relational database should be able to post strong growth as customers continue to depend on its quality features, such as data partitioning which brings incomparable load balancing efficiency.
  • Oracle’s autonomous database and IaaS was built with ease of use in mind, which could bring a significant base of first-time Oracle users to the company, strengthening top line results. 
  • Oracle’s stake in TikTok Global and cloud services to TikTok’s U.S. operations should add a significant boost to Oracle’s top line and attract more “general use” cloud customers.

Company Profile

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.

(Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Global stocks Shares

Capri’s Faces COVID-19 Disruptions and Intense Competition While Working on its brands

Powered by store openings and retail expansion in the 2010-15 period, Michael Kors became one of the largest American handbag producers in sales and units. However, over the past five years, growth has stalled due to markdowns of bags at third-party retail and declining sales at company-owned stores. While Capri has reduced distribution to limit discounting of Michael Kors bags, competition in the American handbag market is fierce and growth is limited. Moreover, the company is in the process of closing more than 100 Michael Kors stores.

Capri spent a steep $3.4 billion to purchase Jimmy Choo and Versace to boost its status as a luxury house and reduce its dependence on Michael Kors. However, we do not think these deals have changed Capri’s no-moat status as the acquired brands have more fashion risk, less profitability, and narrower appeal than Michael Kors. Capri is investing in store remodels, store openings, and expanding the set of accessories for both Jimmy Choo and Versace, but we don’t think these efforts will yield the intended gains, particularly given the severe interruption we expect from COVID-19. 

We believe Michael Kors lacks the brand strength (and ultimately pricing power) to provide an economic moat for Capri, rating poorly on the criteria that Morningstar uses to evaluate luxury brands, in contrast to others such as narrow-moat Tapestry’s Coach.

Financial Strength

Capri has debt, but it is very manageable. At the end of June 2021, it had total shortand long-term debt of $1.3 billion, but it also had more than $350 million in cash. Capri, though, has $1.3 billion in available borrowing capacity it amended its revolving and term loan credit agreement.Thus, Capri has no significant debt maturities prior to 2023. Capri has also recently modified its debt covenants, allowing a maximum leverage ratio of 3.75 times. Its debt/adjusted EBITDA was 2.3 times at the end of fiscal 2021, and we forecast this will decline to 1.2 times at the end of fiscal 2022. The firm averaged more than $500 million in annual buybacks in fiscal 2015-20. We now forecast its share repurchases at an annual average of about $630 million over the next decade. However, Capri does not pay dividends. We forecast its fiscal 2021 capital expenditures will rise to $205 million (3.9% of sales) from just $111 million (2.7% of sales) last year. Long term, we forecast Capri’s annual capital expenditures as a percentage of sales at 4.3% as management works to improve the performance at Jimmy Choo and Versace.

Bulls Say

  • Michael Kors is one of the largest brands in terms of units and sales in the high-margin handbag market, and we think this positioning should aid its prospects as it looks to grow in complementary categories like footwear.
  • Michael Kors has reduced its dependence on wholesale customers, which we view favorably as increased direct-to-consumer sales allow for better pricing and control over marketing.
  • The acquisitions of Jimmy Choo and Versace afford diversification opportunities by bringing two luxury brands that maintain products with high price points into the fold.

Company Profile

Michael Kors, Versace, and Jimmy Choo are the brands that comprise Capri Holdings. Capri markets, distributes, and retails upscale accessories and apparel. Michael Kors, Capri’s largest and original brand, offers handbags, footwear, and apparel through more than 800 company-owned stores, third-party retailers, and e-commerce. Milan-based Versace (acquired in 2018) is known for its ready-to-wear luxury fashion. Jimmy Choo (acquired in 2017) is best known for women’s luxury footwear. John Idol has served as CEO since he was part of a group that acquired Michael Kors in 2003.

 (Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
IPO Watch

Paras Defence launched its IPO; hitting 185% from its issue price and got locked in upper circuit

The Paras Defence and Space Technologies IPO market lot size was 85 shares with a price brand of Rs. 165-175 per share. A retail-individual investor can apply for up to 13 lots (1105 shares or ₹193,375).The face value for each share is Rs. 10 per share and is listed on both BSE and NSE.

Paras Defence IPO Shares offer:

CategoryShare offersAmount (Rs.)
Fresh Issue80,34,286140.60 Cr.
Offer for sale1,724,49030.18 Cr.
Total97,58,776170.78 Cr.

Paras Defence IPO Reservation:

CategoryReservationShare Amount
QIB50%48,79,38885.39 Cr.
NII15%14,63,81625.62 Cr.
RII35%34,15,57259.77 Cr.
Total100%97,58,776170.78 Cr.

Objects of the Issue:

  • Fund capital expenditure requirements.
  • Funding incremental working capital requirements.
  • Repayment or prepayment of all or a portion of certain borrowings/outstanding loan facilities availed by the company.
  • General Corporate purposes.

Summary of Financial Statement (Restated Consolidated)

ParticularsFor the year/period ended (₹ in millions)
31-Mar-2131-Mar-2031-Mar-19
Total Assets3,627.583,423.863,297.48
Total Revenue1,446.071,490.511,571.69
Profit After Tax157.86196.57189.70

Paras Defence and Space Technologies IPO Subscription Status (Bidding Detail)

The Paras Defence and Space Technologies IPO was subscribed 304.26 times on Sep 23, 2021. The quota reserved for qualified institutional buyers category was subscribed about 170 times, the non-institutional investors’ quota 927.70 times and retail individual investors’ (RIIs) portion 113 times.

Paras Defence and Space Technologies shares had a blockbuster debut on the bourses on October 1, rising 185 percent to Rs 498.75 from its issue price of Rs 175 on the BSE.  Since it was a 5 percent rise from the opening price of Rs 475, the share got locked in upper circuit.

Company Profile

Paras Defence and Space Technologies are primarily engaged in the designing, developing, manufacturing, and testing of a variety of defense and space engineering products and solutions. The company has five major product category offerings – Defence & Space Optics, Defence Electronics, Heavy Engineering, Electromagnetic Pulse Protection Solutions, and Niche Technologies. Paras Defence and Space Technologies is the only Indian company with the design capability for space-optics and opto-mechanical assemblies and is one of the leading providers of optics for various Indian defense and space programs. The company also delivers customized turnkey projects in the defense segment. The company has partnered with some of the leading technology companies around the world to indigenize advanced technologies in the defense and space sectors for the Indian market.

The company has 2 manufacturing plants in Maharashtra and is in the process of expanding its current manufacturing facility at Nerul in Navi Mumbai.

(Source: https://parasdefence.com/,)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
LICs LICs

Argo Global provides capital growth, dividend income and diversified portfolio to investors

Smiling young social worker sitting at table with senior lady and explaining document content to her

Being an LIC, it is a close-ended fund with liquidity as it is traded in the secondary market. The total market capitalization is $328.3m and dividend yield is 3.7%.

The Company provides access to a portfolio which is managed by Cohen & Steers; it is a well-regarded asset management firm with a stable, experienced and well-resourced investment team.

The downside of the LIC is that the company has traded primarily at a discount to pre-tax NTA since listing in July 2015. Their management fees are at the higher end in comparison to the listed peer group.

The opportunities offered by this LIC is that it helps investors to diversify their existing portfolio with an infrastructure as an asset class as the returns generated by it are less volatile than the equities market. Investments in infrastructure generally acts as an inflation-hedged income stream.

The portfolio is actively managed and typically hold 50-100 securities. At least 80% of the portfolio will be invested in global listed infrastructure securities, up to 20% can be invested in global infrastructure fixed income securities and up to 5% of the portfolio can be held in cash.

ALI seeks to provide investors a total return, consisting of capital growth and dividend income, from a diversified long-only portfolio of global listed infrastructure securities that outperforms the Benchmark (FTSE Global Core Infrastructure 50/50 Index, net total return, AUD) over the long-term.

About the company:

Argo Global Listed Infrastructure Limited is a Listed Investment Company (LIC) that listed on the ASX in July 2015. Argo Service Company Pty Ltd (ASCO), a wholly-owned subsidiary of Argo Investments Limited (ARG), is the Manager of the Company and has appointed Cohen & Steers as the Portfolio Manager. Cohen & Steers is a global investment manager in long-life assets, including infrastructure, real estate securities, natural resource companies, commodity futures and fixed-income securities.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
ETFs ETFs

VanEck MSCI: A great quality-factor-focussed passive solution for world developed-markets equity

The benchmark is based on its parent index, the MSCI World ex Australia Index, which includes large and mid cap stocks across 22 developed countries. The top 300 ranked securities are chosen to constitute the quality index and cover around 30% to 40% total market capital as the portfolio tilts towards the large companies. No country or a sector constrains are implemented in the quality index, although a 5% limit is imposed for individual holdings.

Portfolio 

The ETF fully mirrors the composition of the MSCI World ex Australia Quality Hedged Index its large holding is Microsoft account for 5.4% of assets, which is effectively diversifies firm-specific risk. Information technology has been the largest sector exposure 38.9%, reflecting the dominance of tech stocks over the developed markets quality growth spectrum. Financial Exposure 4.7% is discernibly underweight compared with the MSCI World ex Australia Index. 

People

Chesler is an industry veteran with more than 25 years of experience across Sunstone partners, perpetual limited and liberty. Hannah joined VanEck investment in 2014 source ETF, where he was part of the investment management team. 

Performance 

QHAL has delivered superlative performance since its launch till August 2021. Its lack to exposure to small and mid-caps, paired with the quality growth orientation of the portfolio stemming from overweighting in information technology and healthcare, have been the drivers of outperformance since inception. However, currency hedging has been the prime contributor to robust performance as the AUD appreciated against the USD over the trailing two years till August 2021. Launched in early 2019, the ETF has outperformed the category index and category average rival by 4.8% and 6.6% till 31 July 2021, ranking in the in the first quintile of its category.

QHAL Performance History.png

About the Fund

QHAL gives investors exposure to a diversified portfolio of quality international companies from developed markets (ex Australia) with returns hedged into Australian dollars. QHAL aims to provide investment returns before fees and other costs which track the performance of the Index.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
ipo IPO Watch

First Watch Restaurant Group Inc announced pricing of Initial Public Offering

The shares are expected to being traded on NASDAQ Global Select Market on 1st October 2021, under the ticker symbol “FWRG” and it is expected to close on 5th October 2021. 

First Watch Restaurant Group Inc. announced the price of its Initial Public offering of 9,459,000 shares of its common stock at a price to the public of $18.00 per share.  

In addition, the company has granted the underwriters a 30 days option price to purchase up to an additional 1,418,850 shares of common stock at the Initial Public Offering price less underwriting discounts and commissions.

At the time of Initial Public Offering their Total Offering Expense is $5,000,000.00 while their total share outstanding is 57,629,596. 

Market capitalization of First Watch Restaurant Group Inc is 1.239 billion. First Watch intends to use the proceeds from the proposed offering to repay borrowings outstanding under its credit facilities.

Company Profile 

First Watch is an award-winning Daytime Dining restaurant concept serving made-to-order breakfast, brunch and lunch using fresh ingredients. First Watch offers traditional favorites, such as pancakes, omelets, sandwiches and salads, alongside specialty items like the Quinoa Power Bowl®, Avocado Toast and the Chickichanga. There are more than 420 First Watch restaurants in 28 states, and the restaurant concept is majority owned by Advent International, one of the world’s largest private-equity firms.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Global stocks Shares

BioNTech’s COVID-19 Vaccine Success Could Help It Build a Moat on mRNA Technology

The emerging biotech’s first commercial vaccine, for COVID-19, received its first authorization in December 2020, and its early-stage pipeline and mRNA technology platforms have caught the eye of several large pharmaceutical companies, resulting in collaborations and partnerships.

Further, the company has a burgeoning vaccine pipeline for infectious diseases. In partnership with the Bill & Melinda Gates Foundation, BioNTech is developing vaccines for HIV and tuberculosis, and the company’s COVID-19 program in partnership with Pfizer and Fosun Pharma was built off an existing partnership with Pfizer for an influenza vaccine. The COVID-19 vaccine, Comirnaty (BNT162b2), quickly progressed through human trials, culminating in authorization in the United States and Europe in December 2020. 

Company’s Future Outlook

We think the vaccine’s excellent efficacy, strong supply, and early leadership on the market all support $35 billion in Comirnaty sales in 2021 and $43 billion in 2022 (BioNTech books half of Pfizer’s gross profits, profit share from other smaller partners, and direct sales in Germany and Turkey). However, the long-term market for coronavirus vaccines is uncertain, and even if there is demand for continued vaccination in the long run, we expect the market to be competitive.

BioNTech’s COVID-19 Vaccine Success Could Help It Build a Moat on mRNA Technology

We believe BioNTech has a positive moat trend due to strengthening intangible assets in its pipeline. Over the next five years, we expect several data readouts, assets progressing through trials, and even the company’s first potential approval. Further, testing new combinations of treatments, which tends to improve efficacy in cancer treatment, will also strengthen the competitive position of BioNTech’s platforms. 

The positive results and subsequent authorization of BNT162b2, BioNTech’s vaccine against SARS-CoV-2, support our positive moat trend rating. While the long-term profit outlook for BNT162b2 remains uncertain, we believe its success demonstrates the potential of the company’s mRNA vaccine platform.

Financial Strength 

BioNTech has historically burned through cash to fund research and development of its pipeline. The company has minimal debt on its balance sheet, as it has funded discovery and development with equity issues,collaboration payments from partnerships with large pharmaceutical firms as well as a large inflow of cash from Comirnaty gross profits in 2021 and 2022 and believe this will continue for long term basis.Outside of BioNTech’s COVID-19 vaccine candidates, we think the earliest approval could arrive in 2023, which would put the company on a path toward steady profitability. Management has taken advantage of a couple of opportunities to acquire early-stage assets and expand its geographic footprint to establish a U.S. research hub at low prices. We expect the near-term focus for capital allocation to remain on its pipeline of vaccines and other therapies.

Bull Says

  • BioNTech’s pipeline, which relies on expertise in mRNA and bioinformatics, will be difficult to replicate by competitors. 
  • BioNTech will be able to command a premium price with its personalized cancer therapies, if successful. 
  • The rapid development of COVID-19 vaccine Comirnaty bodes well for the rest of BioNTech’s pipeline and the future of its mRNA research platform.

Company Profile

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.

 (Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.